Validation of the prospective registry of outcomes in patients electing lung transplantation (PROPEL)
Brief description of study
The research study is being conducted to develop a test to predict a common complication after lung transplant called primary graft dysfunction (PGD). Predicting PGD before using donor organs may help reduce deaths and improve outcomes of patients receiving a lung transplant in the future.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Lung Cancer,Lung Disease
-
Age: Between 18 Years - 99 Years
-
Gender: All
Male and Female Over 18 years of age Lung donors
Updated on
09 Mar 2024.
Study ID: 849795
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
